Phase 2 Oesophageal Cancer Trial, Recruiting (NCT04018872)

Phase 2 Oesophageal Cancer Trial, Recruiting NCT04018872 Sponsor: Dallas VA Medical Center Condition: Oesophageal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04018872 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Oesophageal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with esophageal cancer that has not spread beyond the local area (meaning it has not spread to distant parts of the body)
You have been diagnosed with cancer at the junction where the esophagus (food pipe) meets the stomach, and it has not spread beyond the local area

Who may not be able to join:

You are unable or unwilling to sign a consent form agreeing to take part in the trial
You have an irregular heart rhythm reading (called a QTc interval) above a certain level on a heart tracing test (confirm with trial site)
You have a history of heart failure that has caused symptoms such as breathlessness or swelling
Your liver function blood tests show results more than 3 times higher than the normal range (confirm with trial site)
You are currently pregnant
You have a known allergy to a medication called itraconazole (an antifungal drug)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: David Wang, MD, PhD, North Texas Veterans Healthcare System

Phone: 214-857-0737

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04018872

Sponsor: Dallas VA Medical Center

Phase: Phase 2

Status: Recruiting

Condition: Oesophageal Cancer

Trial contact: 214-857-0737

More information: https://clinicaltrials.gov/study/NCT04018872

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with esophageal cancer that has not spread beyond the local area (meaning it has not spread to distant parts of the body)
You have been diagnosed with cancer at the junction where the esophagus (food pipe) meets the stomach, and it has not spread beyond the local area

Who may not be able to join:

You are unable or unwilling to sign a consent form agreeing to take part in the trial
You have an irregular heart rhythm reading (called a QTc interval) above a certain level on a heart tracing test (confirm with trial site)
You have a history of heart failure that has caused symptoms such as breathlessness or swelling
Your liver function blood tests show results more than 3 times higher than the normal range (confirm with trial site)
You are currently pregnant
You have a known allergy to a medication called itraconazole (an antifungal drug)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Dallas VA Medical Center

Registry

ClinicalTrials.gov

Start date

24 June 2019

Est. completion

24 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage of pathological complete response with itraconazole

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov